Decoupling deISGylating and deubiquitinating activities of the MERS virus papain-like protease

Jozlyn R Clasman1, Renata K Everett1, Karthik Srinivasan1

  • 1Department of Biological Sciences, Purdue University, West Lafayette, IN, USA.

Antiviral Research
|November 26, 2019
PubMed

Insights

Researchers created MERS PLpro enzyme mutants to separate its deubiquitinating (DUB) and deISGylating (deISG) activities, aiding in understanding immune suppression and potential vaccine development for MERS virus.

Area of Science:

  • Virology
  • Structural Biology
  • Immunology

Background:

  • Middle East Respiratory Syndrome (MERS) virus papain-like proteases (PLpro) possess protease, deubiquitinating (DUB), and deISGylating (deISG) activities.
  • These activities contribute to viral infection and suppression of innate immune responses, but their distinct roles remain unclear.
  • Existing research faces challenges in separating the DUB and deISG activities of PLpro.

Purpose of the Study:

  • To determine the structure of MERS PLpro in complex with human ISG15.
  • To design and characterize MERS PLpro mutants with selectively impaired DUB and/or deISG activities.
  • To provide tools for investigating the specific roles of DUB and deISG activities in viral pathogenesis and immune evasion.

Main Methods:

  • Determined the crystal structure of MERS PLpro-ISG15 complex at 2.3 Å resolution.
  • Utilized structural information to design 13 MERS PLpro mutants targeting key amino acid residues.
  • Employed fluorescence-based assays to evaluate protease, DUB, and deISG activities of the wild-type and mutant enzymes.

Main Results:

  • Identified specific amino acid positions (1649, 1653) for selective modulation of DUB activity.
  • Demonstrated that mutations at Val1691 or His1652 completely abolish both DUB and deISG activities.
  • Successfully generated MERS PLpro mutants with distinct enzymatic profiles.

Conclusions:

  • Selective DUB and deISG activity modulation is achievable through targeted mutagenesis of MERS PLpro.
  • The developed mutants serve as valuable tools for dissecting the roles of DUB versus deISG activities in MERS virus infection.
  • These findings may inform the development of novel MERS virus attenuation strategies for vaccine design.

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.5K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
4.9K
Protein Modifications in the RER01:26

Protein Modifications in the RER

Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
6.7K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.1K